Chinook Therapeutics, Inc.
USD40.39
+0.09 (+0.22%)
CEO
Eric L. Dobmeier
IPO Date
2020-10-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$40.31
Prev. Close
$40.30
Day Low
$40.30
Day High
$40.51
52W Low
$18.34
52W High
$40.51
Market Cap
$2.71B
Volume
3.28M
| -7.3 |
| 31 Dec 2020 | FY | 49.0% | -9869.6% | -24.4% | -19.0% | 0.12 | 11.14 | -2.6 |
| 31 Dec 2019 | FY | 96.8% | -271.5% | 113.9% | -298.0% | -0.05 | 5.16 | -5.3 |
| 31 Dec 2018 | FY | 96.1% | -632.0% | -70.5% | -26.7% | 0.00 | 9.27 | -10909.8 |
| 31 Dec 2017 | FY | 96.8% | -532.9% | -38.7% | -20.6% | 0.00 | 8.46 | -29759.5 |
| 31 Dec 2016 | FY | 98.9% | -179.8% | -40.1% | -20.8% | 0.00 | 11.58 | -40773.7 |
| 31 Dec 2015 | FY | 99.9% | -53.7% | -15.0% | -8.1% | 0.00 | 13.66 | -160427.2 |
| -6.8 |
| 31 Dec 2022 | Q4 | 16.2% | -12070.3% | -14.0% | -10.8% | 0.09 | 7.59 | -7.3 |
| 30 Sept 2022 | Q3 | 82.8% | -2170.7% | -11.4% | -9.2% | 0.09 | 8.53 | -6.1 |
| 30 Jun 2022 | Q2 | -2.6% | -9006.7% | -7.4% | -6.3% | 0.08 | 12.60 | -7.2 |
| 31 Mar 2022 | Q1 | 100.0% | -1174.8% | -7.4% | -6.0% | 0.10 | 7.82 | -7.5 |
| 31 Dec 2021 | Q4 | 100.0% | 14.7% | 1.7% | 1.3% | 0.10 | 7.50 | 27.9 |
| 30 Sept 2021 | Q3 | 100.0% | -767400.0% | -11.4% | -8.0% | 0.17 | 7.91 | -4.6 |
| 30 Jun 2021 | Q2 | 100.0% | -125208.8% | -14.3% | -10.4% | 0.14 | 8.55 | -3.6 |
| 31 Mar 2021 | Q1 | 100.0% | -10602.6% | -12.4% | -9.3% | 0.14 | 9.05 | -4.4 |